These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 17313817

  • 21. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
    Wu CC, Wu SY, Liao CY, Teng CM, Wu YC, Kuo SC.
    Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
    [Abstract] [Full Text] [Related]

  • 22. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects.
    Morikawa Y, Kato H, Kashiwagi H, Nishiura N, Akuta K, Honda S, Kanakura Y, Tomiyama Y.
    Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
    [Abstract] [Full Text] [Related]

  • 23. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
    Duvernay M, Young S, Gailani D, Schoenecker J, Hamm HE.
    Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
    [Abstract] [Full Text] [Related]

  • 24. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.
    Adam F, Verbeuren TJ, Fauchère JL, Guillin MC, Jandrot-Perrus M.
    J Thromb Haemost; 2003 Apr; 1(4):798-804. PubMed ID: 12871418
    [Abstract] [Full Text] [Related]

  • 25. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
    Duvernay MT, Temple KJ, Maeng JG, Blobaum AL, Stauffer SR, Lindsley CW, Hamm HE.
    Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
    [Abstract] [Full Text] [Related]

  • 26. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
    Chaudhary PK, Kim S.
    J Vet Sci; 2019 Jan 31; 20(1):10-15. PubMed ID: 30541187
    [Abstract] [Full Text] [Related]

  • 27. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
    Mazharian A, Roger S, Berrou E, Adam F, Kauskot A, Nurden P, Jandrot-Perrus M, Bryckaert M.
    J Biol Chem; 2007 Feb 23; 282(8):5478-87. PubMed ID: 17200114
    [Abstract] [Full Text] [Related]

  • 28. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR.
    J Clin Invest; 1999 Mar 23; 103(6):879-87. PubMed ID: 10079109
    [Abstract] [Full Text] [Related]

  • 29. Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.
    Holinstat M, Colowick NE, Hudson WJ, Blakemore D, Chen Q, Hamm HE, Cleator JH.
    J Thromb Thrombolysis; 2013 Feb 23; 35(2):209-22. PubMed ID: 23054462
    [Abstract] [Full Text] [Related]

  • 30. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
    Lova P, Campus F, Lombardi R, Cattaneo M, Sinigaglia F, Balduini C, Torti M.
    J Biol Chem; 2004 Jun 11; 279(24):25299-306. PubMed ID: 15078882
    [Abstract] [Full Text] [Related]

  • 31. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
    Fälker K, Haglund L, Gunnarsson P, Nylander M, Lindahl TL, Grenegård M.
    Biochem J; 2011 Jun 01; 436(2):469-80. PubMed ID: 21391917
    [Abstract] [Full Text] [Related]

  • 32. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
    Carrim N, Arthur JF, Hamilton JR, Gardiner EE, Andrews RK, Moran N, Berndt MC, Metharom P.
    Redox Biol; 2015 Dec 01; 6():640-647. PubMed ID: 26569550
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
    Kasuda S, Sakurai Y, Shima M, Morimura Y, Kudo R, Takeda T, Ishitani A, Yoshioka A, Hatake K.
    Alcohol Clin Exp Res; 2006 Sep 01; 30(9):1608-14. PubMed ID: 16930224
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, Hamilton JR.
    J Thromb Haemost; 2016 Aug 01; 14(8):1642-54. PubMed ID: 26878340
    [Abstract] [Full Text] [Related]

  • 35. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
    Schlagenhauf A, Kozma N, Leschnik B, Wagner T, Muntean W.
    Transfusion; 2012 Jun 01; 52(6):1253-9. PubMed ID: 22233332
    [Abstract] [Full Text] [Related]

  • 36. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.
    Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson EA, Cazenave JP, Chap H, Gachet C.
    Blood; 1999 Dec 15; 94(12):4156-65. PubMed ID: 10590060
    [Abstract] [Full Text] [Related]

  • 37. C1-inhibitor influence on platelet activation by thrombin receptors agonists.
    Tarandovskiy ID, Buehler PW, Karnaukhova E.
    Clin Appl Thromb Hemost; 2022 Dec 15; 28():10760296221120422. PubMed ID: 35996317
    [Abstract] [Full Text] [Related]

  • 38. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, Covic L, Kuliopulos A.
    Circulation; 2006 Mar 07; 113(9):1244-54. PubMed ID: 16505172
    [Abstract] [Full Text] [Related]

  • 39. Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation.
    Pouget T, Pillois X, Fiore M.
    Thromb Res; 2019 Jan 07; 173():151-154. PubMed ID: 30530120
    [No Abstract] [Full Text] [Related]

  • 40. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM, Jennings LK, Moliterno DJ, Hord E, Ecob R, Tricoci P, Rorick T, Kotha J, Storey RF.
    Platelets; 2015 Jan 07; 26(3):236-42. PubMed ID: 24750101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.